A microfluidic platform enables comprehensive gene expression profiling of mouse retinal stem cells

Brenda L K Coles1, Mahmoud Labib2, Mahla Poudineh3

  • 1Department of Molecular Genetics, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada. derek.van.der.kooy@utoronto.ca.

Lab on a Chip
|October 15, 2021
PubMed
Summary

Researchers developed a new microfluidic platform and cell-surface marker strategy to enrich rare retinal stem cells (RSCs). This breakthrough offers a promising method for cell replacement therapy in treating blindness caused by retinal degeneration.

Related Concept Videos